Nomad Foods Reports Fourth Quarter and Full Year 2022 Financial Results
Nomad Foods (NYSE: NOMD) reported robust financial performance for 2022, achieving record annual revenue of €2.94 billion, up 12.8% year-over-year. The company also reported an Adjusted EPS of €1.68, a rise of 8%. For Q4 2022, revenue increased 6.6% to €750 million, with an Adjusted EBITDA of €113 million. The company plans to achieve 2023 Adjusted EPS between €1.50 and €1.55, assuming mid-single-digit revenue growth. Management notes the resilience of its operating model amid challenging market conditions and highlights the strong cash flow and financial flexibility to drive future growth.
- Record annual revenue of €2.94 billion, a 12.8% increase year-over-year.
- Adjusted EPS rose to €1.68, marking an 8% growth.
- Q4 2022 revenue increased by 6.6% to €750 million.
- Adjusted EBITDA for 2022 up 8% to €524 million, demonstrating operational strength.
- Management expects 2023 Adjusted EPS between €1.50 and €1.55.
- Adjusted gross margin decreased by 120 basis points to 27.7%, impacted by higher raw material costs.
- Organic revenue growth for 2022 was only 1.8%.
- Adjusted operating expenses increased by 12% to €380 million, driven by acquisitions and one-off costs.
Full year Adjusted EPS of
Completes 6th consecutive year of record annual reported revenue, Adjusted EBITDA and Adjusted EPS
2023 Adjusted EPS guidance range of
FELTHAM,
Key operating highlights and financial performance for the fourth quarter 2022, when compared to the fourth quarter 2021, include:
- Reported revenue increased
6.6% to€750 million - Organic revenue increase of
7.7% - Reported Profit for the period of
€37 million - Adjusted EBITDA up slightly to
€113 million - Adjusted EPS of
€0.33
Key operating highlights and financial performance for the full year 2022, when compared to the full year 2021, include:
- Reported revenue increased
12.8% to€2,940 million - Organic revenue increase of
1.8% - Reported Profit for the period of
€250 million - Adjusted EBITDA increased
8% to€524 million - Adjusted EPS of
€1.68
Management Comments
Stéfan Descheemaeker,
Fourth Quarter of 2022 results compared to the Fourth Quarter of 2021
- Revenue increased
6.6% to€750 million . Organic revenue increase of7.7% was driven by a8.1% decline in volume/mix and a15.8% increase in price. - Adjusted gross profit increased
3% to€193 million . Adjusted Gross margin decreased 80 basis points to25.7% driven by higher raw material costs driven by inflation, partially offset by higher pricing. - Adjusted operating expenses increased
9% to€103 million , primarily reflecting a number of one-off costs in the quarter including a€4.5 million Cost of Living payment support package for our employees. - Adjusted EBITDA up slightly to
€113 million and Adjusted Profit after tax decreased1% to€58 million due to the aforementioned factors. - Adjusted EPS remained unchanged at
€0.33 . Reported EPS increased31% to€0.21 .
Year Ended 2022 results compared to the Year Ended 2021
- Revenue increased
12.8% to€2,940 million . Organic revenue increase of1.8% was driven by a5.9% decline in volume/mix and a7.7% increase in price. - Adjusted gross profit increased
8% to€815 million . Adjusted Gross margin decreased 120 basis points to27.7% driven by higher raw material costs driven by inflation, partially offset by higher pricing and the inclusion of the acquisition. - Adjusted operating expenses increased
12% to€380 million driven primarily by the first-time inclusion of our Adriatic region acquisition. - Adjusted EBITDA increased
8% to€524 million and Adjusted Profit after tax increased6% to€293 million , due to the aforementioned factors. - Adjusted EPS increased
8% to€1.68 and Reported EPS increased40% to€1.43 .
2023 Guidance
For the full year 2023, management expects Adjusted EPS of
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results today,
Nomad Foods Contacts
Investor Relations Contacts
Anthony Bucalo
Nomad Foods Limited
+1-914-907-8724
About
Financial Information
Adjusted financial information for the three and twelve months ended
Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EPS is defined as basic earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and twelve months ended
Adjusted Gross Profit and adjusted gross margin exclude acquisition purchase price adjustments within cost of goods sold.
Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of
Please see on pages 8 to 16, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The Company is unable to reconcile, without unreasonable efforts, Adjusted EPS guidance to the most directly comparable IFRS measure.
Nomad Foods Limited As Reported | |||
Statements of Profit or Loss (unaudited) | |||
Three months ended | |||
Three months ended | Three months ended | ||
€m | €m | ||
Revenue | 750.2 | 704.0 | |
Cost of sales | (557.5) | (523.7) | |
Gross profit | 192.7 | 180.3 | |
Other operating expenses | (103.6) | (98.7) | |
Exceptional items | (23.5) | (23.7) | |
Operating profit | 65.6 | 57.9 | |
Finance income | 2.7 | 1.6 | |
Finance costs | (22.0) | (17.2) | |
Net financing costs | (19.3) | (15.6) | |
Profit before tax | 46.3 | 42.3 | |
Taxation | (9.2) | (13.5) | |
Profit for the period | 37.1 | 28.8 | |
Basic earnings per share | |||
Weighted average shares outstanding in millions | 174.2 | 178.1 | |
Basic earnings per share in € | 0.21 | 0.16 | |
Diluted earnings per share | |||
Weighted average shares outstanding in millions | 174.2 | 178.1 | |
Diluted earnings per share in € | 0.21 | 0.16 |
Statements of Profit or Loss (audited) | |||
Twelve months ended | |||
Twelve months | Twelve months | ||
€m | €m | ||
Revenue | 2,939.7 | 2,606.6 | |
Cost of sales | (2,124.4) | (1,862.3) | |
Gross profit | 815.3 | 744.3 | |
Other operating expenses | (391.2) | (356.3) | |
Exceptional items | (48.7) | (45.3) | |
Operating profit | 375.4 | 342.7 | |
Finance income | 12.1 | 0.1 | |
Finance costs | (66.5) | (106.1) | |
Net financing costs | (54.4) | (106.0) | |
Profit before tax | 321.0 | 236.7 | |
Taxation | (71.2) | (55.7) | |
Profit for the period | 249.8 | 181.0 | |
Basic and diluted earnings per share in € | 1.43 | 1.02 |
Nomad Foods Limited As Reported | |||
Statements of Financial Position (audited) | |||
As at | |||
As at | As at | ||
€m | €m | ||
Non-current assets | |||
2,101.6 | 2,099.4 | ||
Intangibles | 2,457.6 | 2,455.7 | |
Property, plant and equipment | 542.9 | 549.4 | |
Other non-current assets | 8.1 | 8.9 | |
Derivative financial instruments | 0.2 | — | |
Deferred tax assets | 100.4 | 128.3 | |
Total non-current assets | 5,210.8 | 5,241.7 | |
Current assets | |||
Cash and cash equivalents | 369.7 | 254.2 | |
Inventories | 457.1 | 410.6 | |
Trade and other receivables | 266.8 | 234.6 | |
Indemnification assets | 1.8 | 9.5 | |
Derivative financial instruments | 19.9 | 20.2 | |
Total current assets | 1,115.3 | 929.1 | |
Total assets | 6,326.1 | 6,170.8 | |
Current liabilities | |||
Trade and other payables | 695.4 | 692.0 | |
Current tax payable | 183.0 | 198.5 | |
Provisions | 36.1 | 39.3 | |
Loans and borrowings | 22.6 | 29.1 | |
Derivative financial instruments | 3.7 | 7.3 | |
Total current liabilities | 940.8 | 966.2 | |
Non-current liabilities | |||
Loans and borrowings | 2,142.3 | 2,198.3 | |
Employee benefits | 132.1 | 244.2 | |
Other non-current liabilities | 1.1 | 1.8 | |
Provisions | 1.3 | 2.9 | |
Derivative financial instruments | 56.6 | 20.8 | |
Deferred tax liabilities | 445.7 | 437.6 | |
Total non-current liabilities | 2,779.1 | 2,905.6 | |
Total liabilities | 3,719.9 | 3,871.8 | |
Net assets | 2,606.2 | 2,299.0 | |
Equity attributable to equity holders | |||
Share capital and capital reserve | 1,596.7 | 1,623.1 | |
Share based compensation reserve | 13.8 | 6.9 | |
Founder Preferred Share Dividend reserve | — | 166.0 | |
Translation reserve | 89.3 | 105.1 | |
Other reserves | 19.8 | 10.5 | |
Retained earnings | 886.6 | 387.4 | |
Total equity | 2,606.2 | 2,299.0 |
Nomad Foods Limited As Reported | |||
Statements of Cash Flows (audited) | |||
For the year ended | |||
For the Year ended | For the Year ended | ||
€m | €m | ||
Cash flows from operating activities | |||
Profit for the period | 249.8 | 181.0 | |
Adjustments for: | |||
Exceptional items | 48.7 | 45.3 | |
Non-cash fair value purchase price adjustment of inventory | — | 8.4 | |
Share based payment expense | 8.1 | 5.1 | |
Depreciation and amortization | 88.6 | 71.6 | |
Loss on disposal and impairment of property, plant and equipment | 0.8 | 0.7 | |
Net finance costs | 54.4 | 106.0 | |
Taxation | 71.2 | 55.7 | |
Operating cash flow before changes in working capital, provisions and | 521.6 | 473.8 | |
Increase in inventories | (61.7) | (23.8) | |
(Increase)/decrease in trade and other receivables | (38.3) | 24.1 | |
Increase/(decrease) in trade and other payables | 5.6 | (25.0) | |
(Decrease)/increase in employee benefits and other provisions | (2.4) | 1.2 | |
Cash generated from operations before tax and exceptional items | 424.8 | 450.3 | |
Payments relating to exceptional items | (65.2) | (48.8) | |
Receipts relating to exceptional items | 24.4 | — | |
Tax paid | (80.2) | (95.2) | |
Net cash generated from operating activities | 303.8 | 306.3 | |
Cash flows from investing activities | |||
Business combinations, net of cash acquired | 0.4 | (597.3) | |
Purchase of property, plant and equipment and intangibles | (79.1) | (79.2) | |
Redemption of investments | — | 16.5 | |
Cash used in investing activities | (78.7) | (660.0) | |
Cash flows from financing activities | |||
Repurchase of ordinary shares | (26.8) | (77.6) | |
Payments related to shares withheld for tax | (2.9) | (22.6) | |
Issuance of new loan principal | 799.3 | 800.0 | |
Repayment of loan principal | (916.2) | (408.7) | |
Payment of lease liabilities | (26.5) | (19.4) | |
Payment of financing fees | (6.5) | (18.7) | |
Interest paid | (54.2) | (36.7) | |
Interest received | 0.6 | 0.1 | |
Proceeds from settlements of derivatives | 124.8 | — | |
Other financing cash flows | 0.3 | (2.0) | |
Net cash (used in)/provided by financing activities | (108.1) | 214.4 | |
Net increase/(decrease) in cash and cash equivalents | 117.0 | (139.3) | |
Cash and cash equivalents at beginning of period | 254.2 | 382.5 | |
Effect of exchange rate fluctuations | (4.4) | 11.0 | |
Cash and cash equivalents at end of period* | 366.8 | 254.2 | |
*Cash and cash equivalents includes bank overdrafts of |
Reconciliation of Non-IFRS Financial Measures | |||||||
(In € millions, except per share data) | |||||||
The following table reconciles adjusted financial information for the three months ended | |||||||
Adjusted Statement of Profit or Loss (unaudited) | |||||||
Three Months Ended | |||||||
€ in millions, except per share data | As reported for the | Adjustments | As Adjusted for the | ||||
Revenue | 750.2 | — | 750.2 | ||||
Cost of sales | (557.5) | — | (557.5) | ||||
Gross profit | 192.7 | — | 192.7 | ||||
Other operating expenses | (103.6) | 1.1 | (a) | (102.5) | |||
Exceptional items | (23.5) | 23.5 | (b) | — | |||
Operating profit | 65.6 | 24.6 | 90.2 | ||||
Finance income | 2.7 | (2.3) | 0.4 | ||||
Finance costs | (22.0) | 3.1 | (18.9) | ||||
Net financing costs | (19.3) | 0.8 | (c) | (18.5) | |||
Profit before tax | 46.3 | 25.4 | 71.7 | ||||
Taxation | (9.2) | (4.8) | (d) | (14.0) | |||
Profit for the period | 37.1 | 20.6 | 57.7 | ||||
Weighted average shares outstanding in millions - basic | 174.2 | — | 174.2 | ||||
Basic earnings per share | 0.21 | 0.33 | |||||
Weighted average shares outstanding in millions - diluted | 174.2 | — | 174.2 | ||||
Diluted earnings per share | 0.21 | 0.33 |
(a) | Share based payment charge including employer payroll taxes of |
(b) | Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on |
(c) | Elimination of a |
(d) | Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in |
Reconciliation of Non-IFRS Financial Measures (continued) | |||
The following table reconciles Adjusted EBITDA for the three months ended | |||
Adjusted EBITDA (unaudited) | |||
Three Months Ended | |||
€ in millions | As reported for the | ||
Profit for the period | 37.1 | ||
Taxation | 9.2 | ||
Net financing costs | 19.3 | ||
Depreciation and amortization | 22.8 | ||
Exceptional items: | |||
Findus Switzerland integration costs | 0.7 | (a) | |
Impairment of customer relationships | 5.8 | (b) | |
Information Technology Transformation program | 0.6 | (c) | |
Business Transformation Program | 10.9 | (d) | |
Distribution network integration | 1.6 | (e) | |
4.0 | (f) | ||
Factory optimization | 0.9 | (g) | |
Settlement of legacy matters | (1.0) | (h) | |
Other Adjustments: | |||
Other add-backs | 1.1 | (i) | |
Adjusted EBITDA (j) | 113.0 |
(a) | Expenses associated with the integration of the Findus Switzerland business acquired on |
(b) | Charge for the impairment of our food service customer relationships in |
(c) | Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(d) | Expenses associated with the start of a multi-year, enterprise-wide transformation and optimization program. Expenses in the |
(e) | Expenses associated with the restructuring of the sales operations in northern |
(f) | Expenses associated with the integration of the |
(g) | Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard |
(h) | Income and expenses associated with the settlement of tax and other liabilities relating to periods prior to acquisition by the |
(i) | Represents the elimination of share based payment charge including employer payroll taxes of |
(j) | Adjusted EBITDA margin of |
Reconciliation of Non-IFRS Financial Measures (continued) | |||||||
The following table reconciles Adjusted financial information for the three months ended | |||||||
Adjusted Statements of Profit or Loss (unaudited) | |||||||
Three Months Ended | |||||||
€ in millions, except per share data | As reported for the | Adjustments | As Adjusted for the | ||||
Revenue | 704.0 | — | 704.0 | ||||
Cost of sales | (523.7) | 6.1 | (a) | (517.6) | |||
Gross profit | 180.3 | 6.1 | 186.4 | ||||
Other operating expenses | (98.7) | 4.3 | (b) | (94.4) | |||
Exceptional items | (23.7) | 23.7 | (c) | — | |||
Operating profit | 57.9 | 34.1 | 92.0 | ||||
Finance income | 1.6 | (1.5) | 0.1 | ||||
Finance costs | (17.2) | 1.0 | (16.2) | ||||
Net financing costs | (15.6) | (0.5) | (d) | (16.1) | |||
Profit before tax | 42.3 | 33.6 | 75.9 | ||||
Taxation | (13.5) | (4.3) | (e) | (17.8) | |||
Profit for the period | 28.8 | 29.3 | 58.1 | ||||
Weighted average shares outstanding in millions - basic | 178.1 | 178.1 | |||||
Basic earnings per share | 0.16 | 0.33 | |||||
Weighted average shares outstanding in millions - diluted | 178.1 | — | 178.1 | ||||
Diluted earnings per share | 0.16 | 0.33 |
(a) | Represents non-cash fair value uplift of inventory recorded as part of the Fortenova acquisition purchase price accounting. |
(b) | Share based payment charge including employer payroll taxes of |
(c) | Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on |
(d) | Elimination a |
(e) | Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction |
Reconciliation of Non-IFRS Financial Measures (continued) | |||
The following table reconciles Adjusted EBITDA for the three months ended | |||
Adjusted EBITDA (unaudited) | |||
Three Months Ended | |||
€ in millions | As reported for the | ||
Profit for the period | 28.8 | ||
Taxation | 13.5 | ||
Net financing costs | 15.6 | ||
Depreciation and amortization | 20.9 | ||
Acquisition purchase price adjustments | 6.1 | (a) | |
Exceptional items: | |||
2.9 | (b) | ||
Factory optimization | 2.6 | (c) | |
Brexit | 0.6 | (d) | |
Findus Switzerland integration costs | 2.5 | (e) | |
Business Transformation Program | 11.7 | (f) | |
Information Technology Transformation program | 4.2 | (g) | |
Settlement of legacy matters | (0.8) | (h) | |
Other Adjustments: | |||
Other add-backs | 4.3 | (i) | |
Adjusted EBITDA (i) | 112.9 |
(a) | Represents non-cash fair value uplift of inventory recorded as part of the Fortenova acquisition purchase price accounting. |
(b) | Expenses associated with the integration of the |
(c) | Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply |
(d) | Expenses related to preparations for the impacts of the |
(e) | Expenses associated with the integration of the Findus Switzerland business acquired on |
(f) | Expenses associated with the start of a multi-year, enterprise-wide transformation and optimization program. Expenses in the |
(g) | Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(h) | Income and expenses associated with tax and other liabilities relating to periods prior to acquisition by the Company. |
(i) | Represents the elimination of share based payment charge including employer payroll taxes of |
(j) | Adjusted EBITDA margin of |
Reconciliation of Non-IFRS Financial Measures (continued) | |||||||
The following table reconciles adjusted financial information for the twelve months ended | |||||||
Adjusted Statement of Profit or Loss (unaudited) | |||||||
Twelve Months Ended | |||||||
€ in millions, except per share data | As reported for the | Adjustments | As Adjusted for the | ||||
Revenue | 2,939.7 | — | 2,939.7 | ||||
Cost of sales | (2,124.4) | — | (2,124.4) | ||||
Gross profit | 815.3 | — | 815.3 | ||||
Other operating expenses | (391.2) | 11.7 | (a) | (379.5) | |||
Exceptional items | (48.7) | 48.7 | (b) | — | |||
Operating profit | 375.4 | 60.4 | 435.8 | ||||
Finance income | 12.1 | (11.5) | 0.6 | ||||
Finance costs | (66.5) | — | (66.5) | ||||
Net financing costs | (54.4) | (11.5) | (c) | (65.9) | |||
Profit before tax | 321.0 | 48.9 | 369.9 | ||||
Taxation | (71.2) | (5.3) | (d) | (76.5) | |||
Profit for the period | 249.8 | 43.6 | 293.4 | ||||
Weighted average shares outstanding in millions - basic | 174.3 | — | 174.3 | ||||
Basic earnings per share | 1.43 | 1.68 | |||||
Weighted average shares outstanding in millions - diluted | 174.3 | — | 174.3 | ||||
Diluted earnings per share | 1.43 | 1.68 |
(a) | Share based payment charge including employer payroll taxes of |
(b) | Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on |
(c) | Elimination of |
(d) | Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in |
Reconciliation of Non-IFRS Financial Measures (continued) | |||
The following table reconciles Adjusted EBITDA for the twelve months ended | |||
Adjusted EBITDA (unaudited) | |||
Twelve Months Ended | |||
€ in millions | As reported for the | ||
Profit for the period | 249.8 | ||
Taxation | 71.2 | ||
Net financing costs | 54.4 | ||
Depreciation and amortization | 88.6 | ||
Exceptional items: | |||
Findus Switzerland integration costs | 8.2 | (a) | |
Impairment of customer relationships | 5.8 | (b) | |
Information Technology Transformation program | 4.4 | (c) | |
Business Transformation Program | 37.0 | (d) | |
Distribution network integration | 2.2 | (e) | |
9.5 | (f) | ||
Factory optimization | 3.5 | (g) | |
Settlement of legacy matters | (28.9) | (h) | |
Release of indemnification assets | 7.0 | (i) | |
Other Adjustments: | |||
Other add-backs | 11.7 | (j) | |
Adjusted EBITDA (k) | 524.4 |
(a) | Expenses associated with the integration of the Findus Switzerland business acquired on |
(b) | Charge for the impairment of our food service customer relationships in |
(c) | Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(d) | Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. |
(e) | Expenses associated with the restructuring of the sales operations in northern |
(f) | Expenses associated with the integration of the |
(g) | Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard |
(h) | Income and expenses associated with the settlement of contingent tax receivables, tax liabilities and other liabilities relating to |
(i) | Charge for the release of shares held in escrow as part of the consideration on the acquisition of the |
(j) | Represents the elimination of share based payment charge including employer payroll taxes of |
(k) | Adjusted EBITDA margin of |
Reconciliation of Non-IFRS Financial Measures (continued) | |||||||
The following table reconciles Adjusted financial information for the twelve months ended | |||||||
Adjusted Statements of Profit or Loss (unaudited) | |||||||
Twelve Months Ended December 31, 2021 | |||||||
€ in millions, except per share data | As reported for the | Adjustments | As Adjusted for the | ||||
Revenue | 2,606.6 | — | 2,606.6 | ||||
Cost of sales | (1,862.3) | 8.4 | (a) | (1,853.9) | |||
Gross profit | 744.3 | 8.4 | 752.7 | ||||
Other operating expenses | (356.3) | 18.7 | (b) | (337.6) | |||
Exceptional items | (45.3) | 45.3 | (c) | — | |||
Operating profit | 342.7 | 72.4 | 415.1 | ||||
Finance income | 0.1 | — | 0.1 | ||||
Finance costs | (106.1) | 41.9 | (64.2) | ||||
Net financing costs | (106.0) | 41.9 | (d) | (64.1) | |||
Profit before tax | 236.7 | 114.3 | 351.0 | ||||
Taxation | (55.7) | (18.7) | (e) | (74.4) | |||
Profit for the period | 181.0 | 95.6 | 276.6 | ||||
Weighted average shares outstanding in millions - basic | 178.1 | — | 178.1 | ||||
Basic earnings per share | 1.02 | 1.55 | |||||
Weighted average shares outstanding in millions - diluted | 178.1 | — | 178.1 | ||||
Diluted earnings per share | 1.02 | 1.55 |
(a) | Represents non-cash fair value uplift of inventory recorded as part of the Findus Switzerland and Fortenova acquisition purchase |
(b) | Share based payment charge including employer payroll taxes of |
(c) | Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the |
(d) | Elimination of |
(e) | Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in |
Reconciliation of Non-IFRS Financial Measures (continued) | |||
The following table reconciles Adjusted EBITDA for the twelve months ended | |||
Adjusted EBITDA (unaudited) | |||
Twelve Months Ended | |||
€ in millions | As reported for the | ||
Profit for the period | 181.0 | ||
Taxation | 55.7 | ||
Net financing costs | 106.0 | ||
Depreciation and amortization | 71.6 | ||
Acquisition purchase price adjustments | 8.4 | (a) | |
Exceptional items: | |||
Findus Switzerland integration costs | 6.2 | (b) | |
Brexit | 5.3 | (c) | |
Information Technology Transformation program | 4.2 | (d) | |
Business Transformation Program | 18.8 | (e) | |
3.5 | (f) | ||
Factory optimization | 4.9 | (g) | |
Settlement of legacy matters | (2.6) | (h) | |
Release of indemnification assets | 5.0 | (i) | |
Other Adjustments: | |||
Other add-backs | 18.7 | (j) | |
Adjusted EBITDA (k) | 486.7 |
(a) | Represents non-cash fair value uplift of inventory recorded as part of the Findus Switzerland and Fortenova acquisition purchase |
(b) | Expenses associated with the integration of the Findus Switzerland business acquired on |
(c) | Expenses related to preparations for the potential adverse impacts of the |
(d) | Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(e) | Expenses associated with the start of a multi-year, enterprise-wide transformation and optimization program. Expenses in the |
(f) | Expenses associated with the integration of the |
(g) | Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and |
(h) | Income and expenses associated with tax and other liabilities relating to periods prior to acquisition by the Company. |
(i) | Charge for the release of shares held in escrow as part of the consideration on the acquisition of the |
(j) | Represents the elimination of share based payment charge including employer payroll taxes of |
(k) | Adjusted EBITDA margin of |
Adjusted Financial Information (continued) | |||||
Appendix 1: Reconciliation from reported to organic revenue growth/(decline) | |||||
Year on Year Growth - | |||||
Three Months Ended | Twelve Months Ended | ||||
YoY change | YoY change | ||||
Reported Revenue Growth | 6.6 % | 12.8 % | |||
Of which: | |||||
Organic Revenue Growth/(Decline) | 7.7 % | 1.8 % | |||
Acquisitions | — % | 10.8 % | |||
Translational FX (a) | (1.1) % | 0.2 % | |||
Total | 6.6 % | 12.8 % |
(a) | Translational FX is calculated by translating data of the current and comparative periods |
Forward-Looking Statements
Forward-Looking Statements and Disclaimers
Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions
and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including
the Company's expectations regarding (i) its future operating and financial performance, including its reiterated guidance with respect
to Adjusted EPS, Adjusted EPS growth for 2023; and; (ii) its ability to successfully capitalize on opportunities and maximize value for its shareholders.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors
that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i)
the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in
successfully identify suitable acquisition targets and adequately evaluate the potential performance of such acquisition targets; (iv) the
Company's ability to successfully implement its strategies (including its M&A strategy) and strategic initiatives and to recognize the
anticipated benefits of such strategic initiatives; (v) the Company's ability to accurately predict the performance of its Green Cuisine
brand and the Findus Switzerland and Fortenova's frozen food businesses' and their impact on the Company's growth; (vi) the
Company's ability to effectively compete in its markets, including the ability of Green Cuisine to effectively compete in Continental
changes or to successfully develop and renovate products; (viii) the effects of reputational damage from unsafe or poor quality food
products; (ix) the risk that securities markets will react negatively to actions by the Company; (x) the adequacy of the Company's cash
resources to achieve its anticipated growth agenda; (xi) increases in operating costs, including labor costs, and the Company's ability
to manage its cost structure; (xii) fluctuations in the availability of food ingredients and packaging materials that the Company uses in
its products; (xiii) the Company's ability to protect its brand names and trademarks; (xiv) new regulations governing the import and
export of goods between the
currency exchange rates, global economic conditions and cross-border agreements that affect the Company's business; (xv) loss of the
Company's financial arrangements with respect to receivables factoring; (xvi) the loss of any of the Company's major customers or a
decrease in demand for its products; (xvii) economic conditions that may affect the Company's future performance including
exchange rate fluctuations; (xviii) the Company's ability to successfully interpret and respond to key industry trends and to realize the
expected benefits of its responsive actions; (xix) the Company's failure to comply with, and liabilities related to, environmental, health
and safety laws and regulations; (xx) changes in applicable laws or regulations; and (xxi) the other risks and uncertainties disclosed in
the Company's public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective
investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the
date of such statements and, except as required by applicable law, the Company does not undertake any obligation to update or revise
publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
No Offer or Solicitation
This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an
invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall
there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of
applicable law.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in
such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such
restrictions.
View original content:https://www.prnewswire.com/news-releases/nomad-foods-reports-fourth-quarter-and-full-year-2022-financial-results-301754396.html
SOURCE
FAQ
What are Nomad Foods' financial results for 2022?
What is Nomad Foods' guidance for Adjusted EPS in 2023?
How did Nomad Foods perform in Q4 2022?
What challenges did Nomad Foods face in 2022?